IGEA has granted the exclusive license for the Cliniporator® electroporation platform to OncoSec Medical Incorporated within the field of use for DNA-based interleukin-12 (IL-12) gene delivery and other immune-modulatory genes.
Two Scientific Abstract on electrochemotherapy will be presented as electronic posters at the 10th European Conference of Interventional Oncology (ECIO).
The contents of this website is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice because of something you have read on this website.
This website does not recommend or endorse any specific tests, physicians, medical products, procedures, opinions, or other information that may be mentioned on the Site.
The site and its contents are provided on an "as is" basis by the public communication department of IGEA S.p.A.